178 results on '"Hessels D"'
Search Results
2. PCA3-based molecular urine analysis for the diagnosis of prostate cancer
3. DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer
4. A 2-gene mRNA urine test for detection of high-grade prostate cancer prior to initial prostate biopsy
5. 10 Prospectieve multicenter-evaluatie van PCA3 + TMPRSS2-ERG als diagnostisch en prognostisch markerpanel voor prostaatkanker
6. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
7. Validatie van een nieuwe urinetest voor klinisch significante prostaatkanker.
8. New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene
9. 383 Multicenter validation study of a urine-based molecular biomarker algorithm to predict high-grade prostate cancer
10. Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer
11. The role of PCA3 in the diagnosis of prostate cancer
12. Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer
13. Prostate cancer antigen 3: diagnostic outcomes in men presenting with urinary prostate cancer antigen 3 scores ≥100
14. Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: a randomized, open-label, parallel-group pilot study
15. 351 QUATTRO, a four gene prognostic biomarker panel for prostate cancer
16. Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis
17. Urinary biomarkers for prostate cancer: a review
18. Recurrent gene fusions in prostate cancer: their clinical implications and uses
19. Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia
20. Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer.
21. Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer.
22. The role of PCA3 in the diagnosis of prostate cancer.
23. The use of PCA3 in the diagnosis of prostate cancer.
24. Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results.
25. Multifocal urothelial cell cancer and p53 mutation analysis
26. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer.
27. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
28. Molecular PCA3 diagnostics on prostatic fluid.
29. The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance.
30. Predictive value of P53 mutations in bladder washings for progression od high risk superficial bladder cancer
31. 913 Prospective multicenter evaluation of PCA3+TMPRSS2-ERG as a diagnostic and prognostic marker panel for prostate cancer
32. Applicability of biomarkers in the early diagnosis of prostate cancer.
33. DD3, a very sensitive and specific merker to detect prostate tumors. Reply to: Gandino O, Santulli M, Cardillo MR, Stigliano A, Toscano V. Correspondence re: J.B. de Kok et al
34. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.
35. 974 PREDICTING PROSTATE BIOPSY OUTCOME IN A SCREENING SETTING PSA, PCA3, A KALLIKREIN PANEL, THE RISKCALCULATOR OR A COMBINATION? ERSPC ROTTERDAM
36. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
37. 786 IDENTIFICATION OF ETS GENE FUSIONS USING AFFYMETRIX EXON 1.0 ARRAYS
38. 896 THE EFFECT OF DUTASTERIDE ON THE PCA3 SCORE: A RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP PILOT STUDY
39. DETECTION OF TMPRSS2-ERG FUSION TRANSCRIPTS AND PCA3 IN URINARY SEDIMENTS MAY IMPROVE DIAGNOSIS OF PROSTATE CANCER
40. p53-independent apoptosis induced by menadione in the human colon carcinoma cell line Caco-2.
41. 114 THE TIME RESOLVED FLUORESCENCE-BASED PCA3 TEST ON URINARY SEDIMENTS AFTER EXTENDED DIGITAL RECTAL EXAMINATION; A DUTCH MULTICENTER VALIDATION OF THE DIAGNOSTIC PERFORMANCE
42. Mulholland drive
43. Comparative analysis of p53 mutations in bladder washings and histologic specimens
44. Rapid microwave stimulated fixation of entire prostatectomy specimens
45. Predictive value of p53 mutations analyzed in bladder washings for progression of high-risk superficial bladder cancer
46. p53‐Independent Apoptosis Induced by Menadione in the Human Colon Carcinoma Cell Line Caco‐2
47. The relationship between hatching egg weight and subsequent performance of broiler chickens.
48. THE PROGNOSTIC VALUE OF PCA3 GENE-BASED ANALYSIS OF URINE SEDIMENTS AFTER EXTENDED DIGITAL RECTAL EXAMINATION
49. DETAILED ANALYSIS OF HISTOPATHOLOGICAL PARAMETERS AND PCA3 TEST RESULTS
50. Correspondence re: J. B. de Kok et al., DD3, a very sensitive and specific marker to detect prostate tumors. Cancer Res., 62: 2695-2698, 2002 (multiple letters)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.